Prescribing benzodiazepines in residential aged-care facilities

Lynda C. Blogg, Nao Suzuki, Malcolm Roberts, Rhonda M. Clifford

    Research output: Contribution to journalReview article

    Abstract

    Background: Benzodiazepines (BZDs) are used to treat sleep disturbances and behavioural and psychological symptoms of dementia in residents of aged-care facilities. Older people are vulnerable to the adverse effects of BZDs. In Australia,guidelines exist for prescribing BZDs,however there are a lack of data comparing prescribing patterns with guidelines. Aim: To review BZD prescribing patterns in residential aged-care facilities and to compare these with best-practice guidelines. Method: A cross-sectional analysis of BZD prescribing for residents aged 65 years and over was undertaken in 6 aged-care facilities. Data on patient demographics and BZD prescribing were obtained from medication charts,medical records and case notes. BZD prescribing patterns were compared to guidelines from the National Prescribing Service and Therapeutic Guidelines. Results: Prescribing data for 193 residents were analysed. 71 (37%) residents were prescribed a BZD,mostly temazepam and oxazepam. The majority of prescriptions complied with the guidelines w'ith respect to dose,but all exceeded the recommended duration of therapy. 55 (77%) residents had comorbidities for which guidelines recommended avoiding BZDs,such as a history of falls. Conclusion: Although the choice and dose of BZD were appropriate,prescribing did not adhere to guidelines because of the extended duration of therapy. Residents with comorbidities where BZDs should be avoided were frequently prescribed a BZD.

    Original languageEnglish
    Pages (from-to)33-36
    Number of pages4
    JournalJournal of Pharmacy Practice and Research
    Volume46
    DOIs
    Publication statusPublished - 1 Nov 2016

    Fingerprint

    Benzodiazepines
    Guidelines
    Practice Guidelines
    Comorbidity
    Oxazepam
    Behavioral Symptoms
    Temazepam
    Medical Records
    Prescriptions
    Dementia
    Sleep
    Therapeutics
    Cross-Sectional Studies
    Demography
    Psychology

    Cite this

    @article{134ef2cec9434c7796e0155920ced594,
    title = "Prescribing benzodiazepines in residential aged-care facilities",
    abstract = "Background: Benzodiazepines (BZDs) are used to treat sleep disturbances and behavioural and psychological symptoms of dementia in residents of aged-care facilities. Older people are vulnerable to the adverse effects of BZDs. In Australia,guidelines exist for prescribing BZDs,however there are a lack of data comparing prescribing patterns with guidelines. Aim: To review BZD prescribing patterns in residential aged-care facilities and to compare these with best-practice guidelines. Method: A cross-sectional analysis of BZD prescribing for residents aged 65 years and over was undertaken in 6 aged-care facilities. Data on patient demographics and BZD prescribing were obtained from medication charts,medical records and case notes. BZD prescribing patterns were compared to guidelines from the National Prescribing Service and Therapeutic Guidelines. Results: Prescribing data for 193 residents were analysed. 71 (37{\%}) residents were prescribed a BZD,mostly temazepam and oxazepam. The majority of prescriptions complied with the guidelines w'ith respect to dose,but all exceeded the recommended duration of therapy. 55 (77{\%}) residents had comorbidities for which guidelines recommended avoiding BZDs,such as a history of falls. Conclusion: Although the choice and dose of BZD were appropriate,prescribing did not adhere to guidelines because of the extended duration of therapy. Residents with comorbidities where BZDs should be avoided were frequently prescribed a BZD.",
    author = "Blogg, {Lynda C.} and Nao Suzuki and Malcolm Roberts and Clifford, {Rhonda M.}",
    year = "2016",
    month = "11",
    day = "1",
    doi = "10.1002/jppr.1277",
    language = "English",
    volume = "46",
    pages = "33--36",
    journal = "Australian Journal of Hospital Pharmacy",
    issn = "0310-6810",
    publisher = "Society of Hospital Pharmacists of Australia",

    }

    Prescribing benzodiazepines in residential aged-care facilities. / Blogg, Lynda C.; Suzuki, Nao; Roberts, Malcolm; Clifford, Rhonda M.

    In: Journal of Pharmacy Practice and Research, Vol. 46, 01.11.2016, p. 33-36.

    Research output: Contribution to journalReview article

    TY - JOUR

    T1 - Prescribing benzodiazepines in residential aged-care facilities

    AU - Blogg, Lynda C.

    AU - Suzuki, Nao

    AU - Roberts, Malcolm

    AU - Clifford, Rhonda M.

    PY - 2016/11/1

    Y1 - 2016/11/1

    N2 - Background: Benzodiazepines (BZDs) are used to treat sleep disturbances and behavioural and psychological symptoms of dementia in residents of aged-care facilities. Older people are vulnerable to the adverse effects of BZDs. In Australia,guidelines exist for prescribing BZDs,however there are a lack of data comparing prescribing patterns with guidelines. Aim: To review BZD prescribing patterns in residential aged-care facilities and to compare these with best-practice guidelines. Method: A cross-sectional analysis of BZD prescribing for residents aged 65 years and over was undertaken in 6 aged-care facilities. Data on patient demographics and BZD prescribing were obtained from medication charts,medical records and case notes. BZD prescribing patterns were compared to guidelines from the National Prescribing Service and Therapeutic Guidelines. Results: Prescribing data for 193 residents were analysed. 71 (37%) residents were prescribed a BZD,mostly temazepam and oxazepam. The majority of prescriptions complied with the guidelines w'ith respect to dose,but all exceeded the recommended duration of therapy. 55 (77%) residents had comorbidities for which guidelines recommended avoiding BZDs,such as a history of falls. Conclusion: Although the choice and dose of BZD were appropriate,prescribing did not adhere to guidelines because of the extended duration of therapy. Residents with comorbidities where BZDs should be avoided were frequently prescribed a BZD.

    AB - Background: Benzodiazepines (BZDs) are used to treat sleep disturbances and behavioural and psychological symptoms of dementia in residents of aged-care facilities. Older people are vulnerable to the adverse effects of BZDs. In Australia,guidelines exist for prescribing BZDs,however there are a lack of data comparing prescribing patterns with guidelines. Aim: To review BZD prescribing patterns in residential aged-care facilities and to compare these with best-practice guidelines. Method: A cross-sectional analysis of BZD prescribing for residents aged 65 years and over was undertaken in 6 aged-care facilities. Data on patient demographics and BZD prescribing were obtained from medication charts,medical records and case notes. BZD prescribing patterns were compared to guidelines from the National Prescribing Service and Therapeutic Guidelines. Results: Prescribing data for 193 residents were analysed. 71 (37%) residents were prescribed a BZD,mostly temazepam and oxazepam. The majority of prescriptions complied with the guidelines w'ith respect to dose,but all exceeded the recommended duration of therapy. 55 (77%) residents had comorbidities for which guidelines recommended avoiding BZDs,such as a history of falls. Conclusion: Although the choice and dose of BZD were appropriate,prescribing did not adhere to guidelines because of the extended duration of therapy. Residents with comorbidities where BZDs should be avoided were frequently prescribed a BZD.

    UR - http://www.scopus.com/inward/record.url?scp=84996528066&partnerID=8YFLogxK

    U2 - 10.1002/jppr.1277

    DO - 10.1002/jppr.1277

    M3 - Review article

    VL - 46

    SP - 33

    EP - 36

    JO - Australian Journal of Hospital Pharmacy

    JF - Australian Journal of Hospital Pharmacy

    SN - 0310-6810

    ER -